By
PharmaSecure
Published: Aug. 18, 2015, 9 a.m.·
Tags:
TB care
New Delhi, India (August 10, 2015) - PharmaSecure, a leading global provider of brand protection and customer engagement solutions, has been one of four organizations selected to advance to phase two of the “Grand Challenges in TB Control” grant program, sponsored by the Gates Foundation and USAID, to find novel solutions to improve the health outcomes of patients with Tuberculosis (TB). Results from the first phase of the program in India showed that patients who were enrolled in PharmaSecure's psConnect™ patient management platform had a 60% increase in reported adherence to the TB drug regimen over non-enrolled patients.
Read More →